28. Does loss of spondylolisthesis reduction impact clinical and radiographic outcomes after minimally invasive transforaminal lumbar interbody fusion?

Minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) is the workhorse minimally invasive treatment for patients with degenerative lumbar stenosis and spondylolisthesis refractory to nonoperative care. While the basic tenets of surgical treatment do not differ between minimally invasive and open techniques, surgeons performing MI-TLIF are more likely to attempt reduction of spondylolisthesis in order to optimize restoration of canal dimensions due to a greater reliance on indirect decompression, which has been shown to be effective.
Source: The Spine Journal - Category: Orthopaedics Authors: Source Type: research